Paper
Organic & Biomolecular Chemistry
General procedure for the radical bromination reaction
J2,F = 23.9 Hz, C-2), 69.9 (d, J3,F = 10.6 Hz C-3), 69.4 (C-4),
54.5 (OCH3), 20.7, 20.6, 20.5 (3 × CH3); ESMS: m/z 415.8.8
A suspension of glycosyl uronate (1 eq.) and N-bromosuccin- [M + Na]+.
amide (2 eq.) in dry CCl4 (10 mL per 1.0 mmol) was heated at
reflux for 4 h under irradiation with a 500 W tungsten lamp.
The reaction mixture was then cooled to r.t. and filtered over
General procedure for AIBN-initiated tributyltin hydride
reduction
celite, and concentrated under reduced pressure. The pure The D-glucuronic acid 5-C-bromide (1 eq.) was dissolved in
bromide was isolated by flash chromatography (hexane : anhydrous benzene (60–80 mM) and stirred under nitrogen.
EtOAc : toluene 1 : 1 : 0.1).
Tributyltin hydride (1.5 eq.) and AIBN (0.1 mol%) were added,
Methyl 1,2,3,4-tetra-O-acetyl-5-C-bromo-β-D-glucopyranosyl- and the reaction mixture was heated at reflux for 2 h. The
uronate (1). Bromination of uronate 3 (0.47 g, 1.2 mmol) via mixture was cooled to r.t., and the solvent was removed under
the general procedure gave the bromide 1 (0.41 g, 75%) as reduced pressure. The residue was purified by flash chromato-
colourless needles, m.p. 103–105 °C (EtOAc/hexane; lit.33 graphy on silica gel (EtOAc : hexane : toluene 1 : 1 : 0.5) to give
159–161 °C). The 1H NMR spectrum was in accord with the the product(s).
literature.30,33 1H NMR (500 MHz, CDCl3): δ 6.26 (d, 1H, J1,2
=
Methyl 1,2,3,4-tetra-O-acetyl-α-L-idopyranuronate (2). The
8.8 Hz, H-1), 5.52 (dd, 1H, J2,3 = J3,4 9.5 Hz, H-3), 5.30 (d, 1H, bromide 1 (0.38 g, 0.8 mmol) was reduced with tributyltin
H-4), 5.22 (dd, H-2), 3.81 (s, 3H, OCH3), 2.11 (s, 3H, CH3), 2.08 hydride according to the general procedure to give 2 (55 mg,
(s, 3H, CH3), 2.03 (s, 3H, CH3), 2.00 (s, 3H, CH3); 13C NMR 17%) and 3 (100 mg, 53%). Data for 2: m.p. 125–126 °C
(125 MHz, CDCl3): δ 169.6, 169.1, 169.0, 168.2, 164.2 (5 × (EtOAc/hexane; lit.28 118–119 °C). [α]D −60.7 (c 0.5, CHCl3).
CvO), 90.8 (C-1), 89.0 (C-5), 70.7 (C-4), 69.8 (C-2), 69.2 (C-3), The 1H and 13C NMR spectra were in accord with the litera-
54.1 (OCH3), 20.6, 20.6, 20.5, 20.5 (4 × CH3); ESMS: m/z 476.9 ture.28,30,38 1H NMR (500 MHz, CDCl3): δ 6.27–6.25 (m, 1H,
[M + Na]+.
H-1), 5.16–5.11 (m, 2H, H-3, H-4), 4.84 (d, J4,5 = 2.6 Hz, H-5),
Methyl 1,2,3,4-tetra-O-acetyl-5-C-bromo-α-D-glucopyranosyl- 4.83 (ddd, 1H, J1,2 = 0.9, J2,3 = 2.2, J2,4 = 3.3 Hz, H-2), 3.78 (s,
uronate (4). Bromination of uronate 6 (0.53 g, 1.4 mmol) via 3H, OCH3), 2.10 (s, 3H, CH3), 2.09 (s, 3H, CH3), 2.08 (s, 3H,
the general procedure gave the bromide 4 (0.25 g, 39%) as a CH3), 2.06 (s, 3H, CH3); 13C NMR (125 MHz, CDCl3): δ 169.3,
colourless oil. 1H and 13C NMR spectra were in accord with the 169.0, 168.6, 168.0, 167.6 (5 × CvO), 90.4 (C-1), 68.2 (C-5), 66.7
literature.29,30 1H NMR (500 MHz, CDCl3): δ 6.51 (d, 1H, J1,2
4.1 Hz, H-1), 5.78 (dd, 1H, J2,3 = 10.1 Hz, J3,4 = 9.8 Hz, H-3), (4 × CH3). ESMS: m/z 399.1 [M + Na]+.
=
(C-3), 66.2 (C-4), 65.9 (C-2), 52.7 (OCH3), 20.8, 20.7, 20.6, 20.5
5.23 (d, 1H, H-4), 5.17 (dd, H-2), 3.80 (s, 3H, OCH3), 2.19 (s,
Methyl 1,2,3,4-tetra-O-acetyl-β-L-idopyranuronate (5). The
3H, CH3), 2.09 (s, 3H, CH3), 2.03 (s, 3H, CH3), 2.02 (s, 3H, bromide 4 (100 mg, 0.22 mmol) was reduced with tributyltin
CH3); 13C NMR (125 MHz, CDCl3): δ 169.5, 169.4, 168.9, 168.5, hydride according to the general procedure to give a mixture of
164.8 (5 × CvO), 89.5 (C-1), 87.1 (C-5), 69.8 (C-3), 67.9 (C-4), 5 and 6 (600 mg, 78%) in a ratio of 3.7 : 1, as determined by 1H
67.0 (C-2), 54.1 (OCH3), 21.2, 20.6, 20.5, 20.3 (4 × CH3); ESMS: NMR spectroscopy. Purification by flash chromatography pro-
m/z 476.9 [M + Na]+.
vided analytical data for 5: colourless oil. [α]D +8.1 (c 0.3,
Methyl (methyl 2,3,4-tri-O-acetyl-5-C-bromo-β-D-glucopyrano- CHCl3; lit.29 +12.3). The 1H and 13C NMR spectra were in
sid)uronate (7). Bromination of uronate 9 (0.41 g, 1.2 mmol) accord with the literature.29,30 1H NMR (500 MHz, CDCl3):
via the general procedure gave the bromide 7 (0.25 g, 49%) as δ 6.03 (d, 1H, J1,2 = 1.9 Hz, H-1), 5.26 (dd, 1H, H-3), 5.08 (ddd,
a colourless oil.28 1H NMR (500 MHz, CDCl3): δ 5.46 (dd, 1H, J = 1.0, 4.0, H-4), 4.99 (ddd, 1H, J = 2.5 Hz, H-2), 4.69 (d, 1H,
J2,3 = J3,4 = 9.5 Hz, H-3), 5.27 (d, 1H, H-4), 5.10 (dd, 1H, J1,2
=
J = 3.5, Hz, H-5), 3.78 (s, 3H, OCH3), 2.12 (s, 3H, CH3), 2.11 (s,
8.3 Hz, H-2), 5.00 (d, H-1), 3.82 (s, 3H, OCH3), 3.53 (s, 3H, 3H, CH3), 2.10 (s, 3H, CH3), 2.09 (s, 3H, CH3); 13C NMR
OCH3), 2.06 (s, 3H, CH3), 2.04 (s, 3H, CH3), 1.98 (s, 3H, CH3); (125 MHz, CDCl3): δ 169.4, 169.2, 168.6, 168.1, 166.8 (5 ×
13C NMR (125 MHz, CDCl3): δ 169.7, 169.2, 168.9, 164.6 (4 × CvO), 89.8 (C-1), 73.3 (C-2), 67.2 (C-5), 66.3 (C-3), 65.3 (C-4),
CvO), 101.6 (C-1), 90.1 (C-5), 70.8 (C-3), 70.1 (C-4), 70.0 (C-2), 52.7 (OCH3), 20.7(4), 20.7(3), 20.7(0), 20.5 (4 × CH3); ESMS: m/z
57.8 (OCH3), 54.0 (OCH3), 20.6, 20.6, 20.5 (3 × CH3); ESMS: m/z 399.1 [M + Na]+.
448.9 [M + Na]+.
Methyl (methyl 2,3,4-tri-O-acetyl-α-L-idopyranoside) uronate
Methyl
(2,3,4-tri-O-acetyl-5-C-bromo-β-D-glucopyranosyl (8). The bromide 7 (30 mg, 0.07 mmol) was reduced with tri-
fluoride) uronate (10). Bromination of uronate 12 (0.37 g, butyltin hydride according to the general procedure to give 8
1.1 mmol) via the general procedure gave the bromide 10 (10 mg, 43%) and 9 (11 mg, 48%). Data for 8: colourless oil.
(0.20 g, 44%) as a colourless oil.31,32 The 13C NMR spectrum [α]D −43.1 (c 0.2, CHCl3; lit.28 −56.5). The 1H and 13C NMR
was in accord with the literature.31 1H NMR (500 MHz, CDCl3): spectra were in accord with the literature.28,38 1H NMR
δ 5.70 (dd, 1H, J1,F 51.2 Hz, J1,2 7.3 Hz, H-1), 5.47 (ddd, 1H, (500 MHz, CDCl3): δ 5.11 (br ddd, 1H, J3,4 = 3.1 Hz, J4,5
=
J3,4 = 9.5 Hz, J2,3 = 10.3 Hz, J3,F = 0.7 Hz, H-3), 5.35 (d, 1H, H-4), 2.6 Hz, H-4), 5.03 (dd, 1H, J3,4 = 3.1 Hz, J2,3 = 4.4 Hz, H-3), 4.88
5.22 (ddd, 1H, J2,F = 23.2 Hz, H-2), 3.85 (s, 3H, OCH3), 2.09 (s, (dd, J1,2 = 1.8 Hz, J1,3 = 1.0 Hz 1H, H-1), 4.80 (d, 1H, J4,5
=
3H, CH3), 2.08 (s, 3H, CH3), 2.00 (s, 3H, CH3); 13C NMR 2.6 Hz, H-5), 4.78–4.76 (m, 1H, H-2), 3.77 (s, 3H, OCH3), 3.42
(125 MHz; CDCl3): δ 169.6, 169.0, 168.8, 163.8 (4 × CvO), (s, 3H, OCH3), 2.09 (s, 3H, CH3), 2.07 (s, 3H, CH3), 2.06 (s, 3H,
106.3 (d, J1,F = 225 Hz, C-1), 87.7 (d, J5,F = 8.0 Hz, C-5), 70.0 (d, CH3); 13C NMR (125 MHz; CDCl3): δ 169.5, 169.4, 169.0, 168.4
Org. Biomol. Chem.
This journal is © The Royal Society of Chemistry 2016